CD4+ T淋巴细胞计数与狼疮肾炎疾病活动度的相关性研究
Correlation Analysis of CD4+ T Cell Count with Disease Activity in Patients with Lupus Nephritis
DOI: 10.12677/ACM.2020.106152, PDF,   
作者: 张媛媛, 董 静*, 王丽芹, 赵 磊, 潘 琳, 钟艳艳:青岛大学附属医院风湿免疫科,山东 青岛;马焕焕:余杭区第一人民医院风湿内分泌科,浙江 杭州
关键词: 系统性红斑狼疮CD4+ T细胞狼疮肾炎SLEDAISystemic Lupus Erythematosus CD4+ T Cell Lupus Nephritis SLEDAI
摘要: 目的:探讨不同疾病活动度的狼疮肾炎(Lupus nephritis, LN)患者血液CD4+ T细胞计数与LN患者疾病活动度的相关性。方法:收集2017年10月至2019年3月在青岛大学附属医院风湿免疫科169例狼疮肾炎(LN)患者临床资料,按照SLE活动指数(systemic lupus erythematosus disease activity index, SLEDAI)分为病情活动组(n = 77)和病情稳定组(n = 92),对照组为同期确诊为SLE且病情稳定的非LN患者(n = 64)。对CD4+ T细胞计数与SLEDAI评分、实验室指标的相关性进行统计学分析。结果:病情活动组CD4+ T细胞计数平均值低于病情稳定组[(227.46 ± 104.34)和(348.91 ± 98.22) cells/μl, P < 0.01];同时低于对照组[(378.88 ± 169.61) cells/μL, (P < 0.01)]。对照组、病情稳定组、病情活动组的CD4+ T细胞计数与SLEDAI评分呈负相关(r = −0.445, P = 0.038; r = −0.419, P = 0.022; r = −0.673, P = 0.001),病情稳定组与病情活动组CD4+ T细胞计数与24小时蛋白尿定量负相关(r = −0.544, P = 0.041; r = −0.629, P = 0.032)。结论:高疾病活动度的LN患者CD4+ T细胞计数明显降低,并与24小时蛋白尿定量负相关,提示临床中可通过监测CD4+ T细胞计数的动态改变判断LN病情活动,指导LN的临床治疗。
Abstract: Objection: To analyze the changes of serum CD4+ T cell count in lupus nephritis (LN) patients with different disease activities, and to investigate the correlation between CD4+ T cell count and clinical manifestations, laboratory examination and disease activity. Methods: A total of 169 patients with LN were divided into active group (n = 77) and stable group (n = 92) according to SLEDAI score. The CD4+ T cell count and the correlation between CD4+ T cell count and SLEDAI score was analyzed among the three groups, as well as analyzed the correlation between the CD4+ T cell count and laboratory indexes. Results: 1) The average count of CD4+ T cell in active groups was significantly lower than stable group [(227.46 ± 104.34) vs (348.91 ± 98.22) cells/μl, P<0.01], and lower than that in control group [(378.88 ± 169.61) cells/μl, (P < 0.01)]; 2) The CD4+ T cell count of all the groups had significant negative correlation with SLEDAI score (r = −0.445, P = 0.038; r = −0.419, P = 0.022; r = −0.673, P = 0.001); 3) The CD4+ T cell count of active group and stable group had a significant negative correlation with 24 hours urinary protein excretion (r = −0.544, P = 0.041; r = −0.629, P = 0.032). Conclusion: The CD4+ T cell count in LN Patients with high disease activity was significantly decreased and negatively correlated with 24-hour albuminuria. Our study suggests that the disease activity of LN can be assessed by monitoring the change of CD4+ T cell count, thus benefit the clinical treatment of LN.
文章引用:张媛媛, 董静, 马焕焕, 王丽芹, 赵磊, 潘琳, 钟艳艳. CD4+ T淋巴细胞计数与狼疮肾炎疾病活动度的相关性研究[J]. 临床医学进展, 2020, 10(6): 1004-1010. https://doi.org/10.12677/ACM.2020.106152

参考文献

[1] Melderis, S., Wiech, T., Iking-Konert, C. and Steinmetz, O.M. (2018) Lupusnephritis. Zeitschrift Für Rheumatologie, 77, 1-16. [Google Scholar] [CrossRef] [PubMed]
[2] Mesquita Jr., D., Kirsztajn, G.M., Franco, M.F., et al. (2017) CD4+ T Helper Cells and Regulatory T Cells in Active Lupus Nephritis: An Imbalance towards a Predominant Th1 Response? Clinical & Experimental Immunology, 191, 50-59. [Google Scholar] [CrossRef] [PubMed]
[3] Bombardier, C., Gladman, D.D., Urowitz, M.B., et al. (1992) Derivation of the Sledai. A Disease Activity Index for Lupus Patients. Arthritis and Rheumatology, 35, 630-640. [Google Scholar] [CrossRef] [PubMed]
[4] Petri, M., Orbai, A.M., Alarcón, G.S., et al. (2012) Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology, 64, 2677-2686. [Google Scholar] [CrossRef] [PubMed]
[5] Yu, F., Haas, M., Glassock, R., et al. (2017) Redefining Lupus Nephritis: Clinical Implications of Pathophysiologic Subtypes. Nature Reviews Nephrology, 13, 483-495. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, H., Xu, J., Zhang, X., et al. (2017) Tubular Basement Membrane Immune Complex Deposition Is Associated with Activity and Progression of Lupus Nephritis: A Large Multicenter Chinese Study. Lupus, 27, 545-555. [Google Scholar] [CrossRef] [PubMed]
[7] 刘亚. CD4+ T细胞亚群在狼疮肾炎中的免疫病理作用研究进展[J]. 中国医师杂志, 2015, 17(7): 1115-1117.
[8] 岳利环, 林进. CD4+ T淋巴细胞亚群在自身免疫性疾病中的研究进展[J]. 中华微生物学和免疫学杂志, 2012, 32(5): 477-480.
[9] Wang, X.L., Qiu, C.L., Wu, X.M., et al. (2010) Study on the Apoptosis of T Lymphocytes of Peripheral Blood in Systemic Lupus Erythematosus (SLE) and the Correlated Pathogenesis. Chinese Journal of Immunology, 2, 48-353+359.
[10] Katsuyama, T., Tsokos, G.C. and Moulton, V.R. (2018) Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. Frontiers in Immunology, 9, 1088. [Google Scholar] [CrossRef] [PubMed]
[11] Samia, F., Mohamed, E. and Azza, A. (2014) Lymphopenia and Systemic Lupus Erythematosus, a Preliminary Study: Correlation with Clinical Manifestations, Disease Activity and Damage Indices. The Egyptian Rheumatologist, 36, 125-130. [Google Scholar] [CrossRef
[12] Zucchi, D., Elefante, E., Calabresi, E., et al. (2019) One Year in Review 2019: Systemic Lupus Erythematosus. Clinical and Experimental Rheumatology, 37, 715-722.
[13] 刘丹, 张舒, 雷婷, 等. 血液相关指标与系统性红斑狼疮活动性分析[J]. 标记免疫分析与临床, 2019(5): 741-744.